The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction. Sign up here to receive weekly updates straight to your inbox.

A new executive order created the Great American Recovery Initiative, and HHS announced several accompanying new programs and policies to support addiction treatment and recovery.
NIH panels that review grant applications are losing members, threatening the agency's ability to distribute funding in coming months.
Billed as an overdose reversal medication built for the fentanyl era, Opvee went bust without buy-in from people who use drugs and harm reduction organizations.
View our curated digest of the latest research news, including the finding that underage youth report significantly higher exposure to cannabis marketing than adults—reaching 63.0% among those aged 16–20. This trend persists even in states with robust regulations, suggesting that while comprehensive bans on traditional channels like billboards and at sports events effectively reduce "physical" exposure, digital and social media environments remain a pervasive and largely unregulated frontier.
The House approved HHS funding last week ahead of the deadline for a partial government shutdown Friday, but major barriers remain in the Senate.
FDA held a meeting last week to consider whether Philip Morris International should be allowed to advertise its Zyn nicotine pouches as a less-harmful alternative to smoking cigarettes.
SAMHSA released new guidance for health care practitioners on integrated, evidence-based care for co-occurring eating disorders and substance use disorders.
View our curated digest of the latest research news, including how different addictive substances affect sleep in different ways. Some patterns appear across multiple drugs, and in certain cases, the same substance causes changes in both how people actually sleep (measured objectively) and how they feel they're sleeping (what they report). More research is needed to systematically compare how different substances specifically impact sleep.
Provisional CDC data shows that overdose deaths have continued to decline, with deaths down 21% in the 12-month period ending August 2025 compared to the year before.
Data from the federal Office of Personnel Management shows that HHS started the year with 18% fewer employees than in 2024, with SAMHSA losing nearly half of its employees.
The Congressional Budget Office released a report on the effectiveness and likely budgetary impacts of various policy approaches to address the opioid crisis.
The American Medical Association released its 2025 report on substance use, describing the complex nature of the ongoing overdose crisis and providing recommendations to remove barriers to treatment and strengthen prevention and harm reduction efforts.
View our curated digest of the latest research news, including how increased alcohol consumption on cannabis co-use days drives higher rates of negative outcomes for young adults. These findings suggest that the total number of drinks is the primary driver of consequences, reinforcing that reducing alcohol intake remains the most effective harm-reduction strategy during combined use.
On Tuesday night, SAMHSA sent letters to thousands of organizations cancelling grants for mental health and addiction services. On Wednesday night, the grants were restored.
A new study suggests that the recent decline in U.S. overdose deaths was driven in large part by a drop in fentanyl potency resulting from Chinese government crackdowns on the trafficking of precursor chemicals.
View our curated digest of the latest research news, including a study that found the proportion of US substance use disorder treatment facilities offering medications for alcohol use disorder (MAUD) increased from 2017 to 2021, but growth then plateaued. Policies supporting the expansion of MAUD-providing facilities, particularly in underserved counties, may be needed to address persistent gaps in access.
An updated version of the Dietary Guidelines for Americans suggests limiting alcohol consumption but removes the specific recommendation of no more than 1-2 drinks per day.
The Senate voted to confirm journalist Sara Carter to lead the Office of National Drug Control Policy.
A recent article from STAT highlights areas in drug policy to keep an eye on in 2026, including marijuana, psychedelics, and opioid overdose deaths.
The U.S. seized Venezuelan leader Nicolás Maduro and charged him and others with narco-terrorism and conspiracy to import cocaine.
President Trump signed an executive order to try to expedite marijuana's rescheduling from Schedule I to III.
View our curated digest of the latest research news, including a study of methadone patients with mental health disorders (MHD) and using methamphetamine that identified key barriers to mental health care: low awareness, stigma, family burden, polysubstance use, and a shortage of specialists. When MHD services were included in methadone clinics, there were improved diagnoses, streamlined referrals, and reduced logistical challenges.
The 2025 Monitoring the Future survey found that teens' use of most substances remains low and has not rebounded to pre-pandemic levels.
President Trump signed an executive order to classify fentanyl as a weapon of mass destruction, a move likely aimed at justifying military action against drug trafficking, though experts doubt it will help address the addiction crisis.
The Senate rejected legislation to extend the enhanced ACA subsidies, while the House passed a health care bill that does not address the subsidies, leaving them to expire at the end of the year.
1 2 3 56